| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | TWST Twist Bioscience Corp | Cho Dennis | See Remarks | Sell | 6,515 | $31.44 | $204,859.61 | -5.1% | |
| Oct 30, 2025 | TWST Twist Bioscience Corp | Finn Patrick John | President And COO | Sell | 17,606 | $31.44 | $553,608.35 | -6.1% | |
| Oct 30, 2025 | TWST Twist Bioscience Corp | Green Paula | SVP Of Human Resources | Sell | 6,920 | $31.44 | $217,594.56 | -4.6% | |
| Oct 30, 2025 | TWST Twist Bioscience Corp | Werner Robert F. | Chief Accounting Officer | Sell | 1,016 | $31.44 | $31,947.41 | -2.0% | |
| Oct 30, 2025 | TWST Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Sell | 5,517 | $31.44 | $173,478.20 | -4.7% | |
| Oct 30, 2025 | TWST Twist Bioscience Corp | Leproust Emily M. | Chief Executive Officer | Sell | 31,379 | $31.44 | $986,690.69 | -4.1% | |
| Oct 30, 2025 | MEDP Medpace Holdings, Inc. | Davenport Fred B Jr | Director | Sell | 5,972 | $581.88 | $3,474,987.36 | -63.1% | |
| Oct 29, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,158 | $136.54 | $294,654.16 | -23.9% | |
| Oct 29, 2025 | IQV Iqvia Holdings Inc. | Bousbib Ari | See Remarks | Sell | 56,557 | $220.33 | $12,461,119.18 | -1.1% | |
| Oct 29, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin | Chief Financial Officer | Sell | 388 | $136.54 | $52,977.52 | -9.4% | |
| Oct 29, 2025 | IQV Iqvia Holdings Inc. | Sherbet Eric | See Remarks | Sell | 4,000 | $219.70 | $878,800.00 | -12.9% | |
| Oct 29, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes | Chief Financial Officer | Sell | 3,045 | $190.72 | $580,734.34 | -0.7% | |
| Oct 29, 2025 | MEDP Medpace Holdings, Inc. | Geiger Jesse J | President | Sell | 3,568 | $585.00 | $2,087,280.00 | -8.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.